Rhinosinusitis Chronic Clinical Trial
Official title:
Comparison of Inhalational Anesthesia With Intravenous Tranexamic Acid and Total Intravenous Anesthesia on Surgical Field Quality in Endoscopic Sinus Surgery
The goal of this interventional study is to compare the efficacy (surgical field quality and intra-operative blood loss) or cost of TIVA alone to general inhalational anesthetics with intravenous TXA in patient participants who are undergoing endoscopic sinus surgery. The main questions the study aims to answer are: - Is the surgical field quality better when using TIVA alone compared to general inhalational anesthetics with intravenous TXA? - Is one method more financially advantageous to the participant and the institution compared to the other method? Participants will be randomized into one of the two anesthesia cohorts prior to sinus surgery. One group will be given total intravenous anesthesia (TIVA) alone and the other will be given intravenous tranexamic acid (TXA) followed by general inhalational anesthesia. Researchers will compare the TIVA group to the TXA group to see if one group exhibits a better surgery field viewing quality through a subjective evaluation and measurement of blood loss and also which anesthesia regimen is most cost effective upon conducting a cost analysis.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | July 1, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - adults (age =18 years) - will undergo endoscopic sinus surgery at Our Lady of the Lake Regional Medical Center - includes patients who are undergoing endoscopic sinus surgery for myriad of indications, such as chronic rhinosinusitis, sinonasal tumors, and encephalocele repairs. - includes patients who undergo both complete functional endoscopic sinus surgery, or FESS (i.e maxillary antrostomy, sphenoethmoidectomy, and frontal sinusotomy), as well as those who are undergoing limited functional endoscopic sinus surgeries (i.e. anything less than a complete FESS). Exclusion Criteria: - <18 years of age - history of bleeding or coagulation disorder - currently receiving anticoagulation therapy - underlying condition with increased risk of thrombosis (e.g. antiphospholipid syndrome), - history of thromboembolic disorder - history of chronic kidney disease - known allergy to tranexamic acid |
Country | Name | City | State |
---|---|---|---|
United States | Our Lady of the Lake Hospital | Baton Rouge | Louisiana |
Lead Sponsor | Collaborator |
---|---|
Our Lady of the Lake Hospital | Louisiana State University Health Sciences Center in New Orleans |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Surgical Field Quality | Surgical field quality during surgery | Field quality measured Every 30 minutes over 4.5 hours of time using the Boezaart grading system. | |
Primary | Intraoperative Blood loss | Intraoperative blood loss at completion of surgery | Measured once at the conclusion of surgery by measuring the total amount of fluid in the suction canisters minus the total amount of irrigation used | |
Secondary | Cost Effectiveness between TIVA and TXA | Comparison of cost of medications used for the TIVA arm to the arm with general anesthetics and TXA will be determined. | Analysis Within 1 year of the procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05923047 -
Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.
|
Phase 4 | |
Not yet recruiting |
NCT05836935 -
Role of Imaging in Complications of Sinusitis
|
N/A | |
Not yet recruiting |
NCT05167552 -
Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04420052 -
Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis
|
N/A | |
Completed |
NCT04703673 -
Sinolpan® Pharmacy Non-interventional Study - Quality of Live
|
||
Recruiting |
NCT05015530 -
Impact of Symbiofilm On Nasal Microbiota
|
||
Not yet recruiting |
NCT06105346 -
Prevalence of ENT Diseseas
|
||
Recruiting |
NCT05450471 -
Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis
|
Phase 3 | |
Terminated |
NCT03675022 -
Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
|
Early Phase 1 |